Beijing Tiantan Biological Products Corp Ltd (600161) — Capital Reinvestment Ratio
Beijing Tiantan Biological Products Corp Ltd (600161) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥318.80 Million) in capital expenditures (CN¥125.07 Million). Check Beijing Tiantan Biological Products Corp tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Tiantan Biological Products Corp Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Beijing Tiantan Biological Products Corp Ltd's Capital Reinvestment Ratio across 27 annual periods. For the full cash flow conversion analysis, see Beijing Tiantan Biological Products Corp (600161) cash conversion ratio.
Annual Capital Reinvestment Ratio for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. See 600161 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.30x | CN¥819.78 Million | CN¥1.07 Billion | ▲ +189.2% |
| 2023 | 0.45x | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -62.6% |
| 2022 | 1.20x | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +4.2% |
| 2021 | 1.15x | CN¥980.35 Million | CN¥1.13 Billion | ▲ +33.1% |
| 2020 | 0.87x | CN¥702.11 Million | CN¥608.91 Million | ▲ +5.9% |
| 2019 | 0.82x | CN¥642.47 Million | CN¥526.23 Million | ▲ +88.9% |
| 2018 | 0.43x | CN¥677.92 Million | CN¥293.90 Million | ▼ -34.6% |
| 2017 | 0.66x | CN¥218.39 Million | CN¥144.87 Million | ▲ +35.7% |
| 2016 | 0.49x | CN¥428.37 Million | CN¥209.39 Million | ▼ -23.0% |
| 2015 | 0.64x | CN¥473.26 Million | CN¥300.57 Million | ▼ -34.6% |
| 2014 | 0.97x | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥23.71 Million | CN¥57.61 Million | — |